In an update of our 2021 edition of this paper, we combine new data from Ipsos’ Global Oncology Monitor with our current therapy expertise and market insight to outline the considerations and challenges for professionals who market, or conduct marketing research for, oncology products.
The fundamentals of the disease and its treatment are discussed, as well as specific developments such as biomarker testing, the ongoing rise of immunotherapy, cell and gene therapies, and Multi-cancer Early Detection Tests. We conclude by looking at the implications for marketers.
ESG: A hidden driver of brand success in healthcare
Global concerns are usually dominated by immediate issues. But when we ask what worries the world, our data show that climate change, poverty and social inequality remain the constant and significant worries that unite people across the globe. But, what does ESG mean for life science companies and the healthcare industry?